PROGNOSTIC VALUE OF PRE-RADIOTHERAPY FDG-PET IN ADVANCED HODGKIN' S DISEASE TREATED BY BEACOPP CHEMOTHERAPY REGIMEN

被引：0
|
作者：
Chiesa, S. [1 ]
De Santis, M. C. [1 ]
Teofili, L. [2 ]
Manfrida, S. [1 ]
Vannata, B. [2 ]
Frascino, V. [1 ]
Fiorentino, A. [1 ]
Calcagni, L. [3 ]
Hohaus, S. [2 ]
Balducci, M. [1 ]
机构：
[1] Catholic Univ, Policlin Univ A Gemelli, Radiol Dept, Rome, Italy
[2] Catholic Univ, Policlin Univ A Gemelli, Haematol & Oncol Day Unit, Rome, Italy
[3] Catholic Univ, Policlin Univ A Gemelli, Nucl Med, Rome, Italy
来源：
RADIOTHERAPY AND ONCOLOGY | 2010年 / 94卷
关键词：
D O I：
10.1016/S0167-8140(15)34534-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
115
引用
收藏
页码：S44 / S45
页数：2
相关论文
共 50 条
  • [31] Prognostic Value of FDG-PET/CT Parameters in Patients with Locally Advanced Rectal Cancer Treated with Neoadjuvant Approach
    Sert, Fatma
    Oral, Aylin
    Savas, Recep
    Yalman, Deniz
    Ozkok, Serdar
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2020, 35 (02): : 134 - 143
  • [32] Severe bone toxicity in young patients with Hodgkin's disease treated with the BEACOPP regimen.
    Symeonidis, A
    Kouraklis, A
    Fragopanagou, E
    Giannakoulas, N
    Tiniakou, M
    Matsouka, P
    Zoumbos, N
    BLOOD, 2001, 98 (11) : 340A - 340A
  • [33] Dose-escalated BEACOPP chemotherapy improves survival in advanced Hodgkin's disease
    不详
    CLINICAL LYMPHOMA, 2004, 5 (03): : 145 - 146
  • [34] Prognostic value of interim FDG-PET in Hodgkin lymphoma: systematic review and meta-analysis
    Adams, Hugo J. A.
    Nievelstein, Rutger A. J.
    Kwee, Thomas C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 170 (03) : 356 - 366
  • [35] Prognostic Value of Metabolic FDG-PET Response in Locally Advanced NSCLC: A Literature Review
    Van De Kerkhove, Charlotte
    Dooms, Christophe
    Vansteenkiste, Johan
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S874 - S875
  • [36] Prognostic value of pretreatment FDG-PET features in laryngeal cancer patients treated with RT
    Kabarriti, R.
    Brodin, P. N.
    Berkowitz, A. Ginsburg
    Ingber, A.
    Ohri, N.
    McGovern, K. P.
    Modi, C.
    Ow, T. J.
    Tassler, A.
    Packer, S.
    Schiff, B. A.
    Smith, R. V.
    Haigentz, M.
    Guha, C.
    Kalnicki, S.
    Tome, W. A.
    Garg, M. K.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S527 - S528
  • [37] Value of FDG-PET in the initial staging of non-Hodgkin's lymphomas: Comparison with computed tomography and prognostic implications
    Sattar, T
    Lilien, D
    Griffeth, L
    Latifi, H
    Glass, J
    Munker, R
    BLOOD, 2003, 102 (11) : 635A - 635A
  • [38] Predictive value of interim FDG-PET during neoajuvant chemotherapy in patients treated for locally advanced breast cancer.
    Musto, A.
    Zamagni, C.
    Ambrosini, V.
    Nanni, C.
    Rosati, M.
    Kumar, R.
    Alavi, A.
    Sansovini, M.
    Farsad, M.
    Montini, G.
    Franchi, R.
    Palucci, A.
    Pettinato, C.
    Castellucci, P.
    Fanti, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S200 - S200
  • [39] PROGNOSTIC VALUE OF FDG-PET BEFORE AUTOLOGOUS TRANSPLANTATION IN RELAPSING/REFRACTORY HODGKIN'S LYMPHOMA: A SINGLE CENTRE EXPERIENCE
    Giordano, A.
    Gaudio, F.
    Perrone, T.
    De Risi, C.
    Spina, A.
    Laddaga, F.
    Scardino, S.
    Merenda, N.
    Rubini, G.
    Liso, V.
    Specchia, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 626 - 626
  • [40] Advanced Hodgkin’s lymphoma: End-of-treatment FDG-PET should be maintained
    Elif Hindié
    Charles Mesguich
    Krimo Bouabdallah
    Noël Milpied
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1254 - 1257
12345